In December 2024, China witnessed a notable surge in respiratory viral infections, with the Chinese CDC highlighting the increase in human metapneumovirus (hMPV) cases specifically in northern regions. This virus typically flourishes during colder months, a pattern observed in the EU/EEA, which is concurrently facing heightened respiratory viral activity, particularly influenza, yet remains within expected seasonal norms.
The Chinese CDC has reported a rise in respiratory infections, particularly hMPV, in northern China as of December 2024. While the EU/EEA has also seen increased respiratory virus cases, this is consistent with expected seasonal patterns. The situation is being monitored, and preparations are advised to mitigate transmission in healthcare settings.
The increase in respiratory infections in China, while notable, appears to align with seasonal trends seen in other regions. The current situation reflects a typical rise in respiratory viruses, which, while concerning, does not present a heightened risk for the EU/EEA. Continuous monitoring and collaborative efforts among health organizations are recommended to manage the spread and impact of these infections.
Original Source: www.ecdc.europa.eu
